Storm Therapeutics

Home | Harnessing the power of RNA epigenetics | Cambridge, UK

Cambridge, United States · Founded 2015 · $119.4M raised

Headquarters
Cambridge
Employees
11–50
Founded
2015
Business Model
B2B
Total Funding
$119.4M
Last Round
$56.0M Series CMay 2026
Rounds
4

About

Storm Therapeutics is a clinical-stage biotechnology company founded in 2015 as a University of Cambridge spin-out, pioneering cellular reprogramming through RNA modifications to treat cancer, inflammation, viruses, and CNS diseases. Its drug discovery platform targets RNA-modifying enzymes to develop small molecule inhibitors, with lead program STC-15 currently in Phase 2 clinical trials for sarcoma.

Summary

Storm Therapeutics is a Biotech company based in Cambridge, United States, founded in 2015. It has raised $119.4M in total across 4 rounds, most recently a $56.0M Series C round in May 2026. Investors include Pfizer Ventures, Cambridge Innovation Capital and M Ventures.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series CSeries CMay 2026
$56.0M

Sign up to see all 4 rounds

Series A through Series C — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Storm Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/storm-therapeutics"><img src="https://indexed.vc/api/badge/company/storm-therapeutics" alt="Storm Therapeutics on Indexed.vc" width="260" height="76" /></a>